Nuclear receptor 4A2 (NR4A2) is a druggable target for glioblastomas.
Karki K, Li X, Jin UH, Mohankumar K, Zarei M, Michelhaugh SK, Mittal S, Tjalkens R, Safe S.
Karki K, et al. Among authors: li x.
J Neurooncol. 2020 Jan;146(1):25-39. doi: 10.1007/s11060-019-03349-y. Epub 2019 Nov 21.
J Neurooncol. 2020.
PMID: 31754919
Free PMC article.